VTYX

Ventyx Biosciences (VTYX)

Ventyx Biosciences Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:VTYX

1 2 3 4 5 6 7 8 9 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/12	05 : 47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/06/07	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/06/06	05 : 21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/06/06	05 : 01	GlobeNewswire Inc.	Ventyx Biosciences Announces Positive Preclinical Data for CNS-Penetrant NLRP3 Inhibitor VTX3232 Demonstrating Reversal of Obesity and Improvements in Cardiometabolic and Inflammatory Markers	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/05/17	05 : 05	GlobeNewswire Inc.	Ventyx Biosciences to Participate in Three Upcoming Investor Conferences	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/05/16	21 : 12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/05/16	21 : 00	GlobeNewswire Inc.	Ventyx Biosciences Announces Appointment of Matthew Moore as Chief Operating Officer	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/05/10	05 : 16	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/05/10	05 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/05/10	05 : 01	GlobeNewswire Inc.	Ventyx Biosciences Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Progress	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/05/03	05 : 05	GlobeNewswire Inc.	Ventyx Biosciences to Report First Quarter 2024 Financial Results on May 9, 2024	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/04/26	18 : 45	PR Newswire (US)	The Gross Law Firm Reminds Ventyx Biosciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 30, 2024 - VTYX	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/04/19	19 : 00	PR Newswire (US)	Ventyx Biosciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before April 30, 2024 to Discuss Your Rights - VTYX	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/04/16	18 : 45	PR Newswire (US)	The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 30, 2024 in Ventyx Biosciences, Inc. Lawsuit - VTYX	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/04/12	18 : 45	PR Newswire (US)	The Gross Law Firm Reminds Ventyx Biosciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 30, 2024 - VTYX	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/04/09	19 : 10	PR Newswire (US)	Investors in Ventyx Biosciences, Inc. Should Contact The Gross Law Firm Before April 30, 2024 to Discuss Your Rights - VTYX	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/04/05	18 : 45	PR Newswire (US)	Investors who lost money on Ventyx Biosciences, Inc.(VTYX) should contact The Gross Law Firm about pending Class Action - VTYX	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/03/29	18 : 45	PR Newswire (US)	The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 30, 2024 in Ventyx Biosciences, Inc. Lawsuit - VTYX	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/03/26	18 : 45	PR Newswire (US)	Ventyx Biosciences, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - VTYX	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/03/11	22 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/03/11	20 : 00	GlobeNewswire Inc.	Ventyx Biosciences Reports Clinical Data for its NLRP3 Inhibitor Portfolio and Provides Pipeline Updates at Virtual Investor Event	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/03/11	18 : 45	PR Newswire (US)	The Gross Law Firm Reminds Ventyx Biosciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 30, 2024 - VTYX	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/03/09	06 : 05	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/03/07	22 : 45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/03/07	22 : 00	GlobeNewswire Inc.	Ventyx Biosciences Announces $100 Million Private Placement of Common Stock	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/03/07	19 : 45	PR Newswire (US)	Class Action Filed Against Ventyx Biosciences, Inc. (VTYX) Seeking Recovery for Investors - Contact The Gross Law Firm	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/03/06	22 : 00	GlobeNewswire Inc.	Ventyx Biosciences to Participate in Two Upcoming Investor Conferences	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/03/04	22 : 00	GlobeNewswire Inc.	Ventyx Biosciences to Host Virtual Investor Event on March 11, 2024	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/02/28	06 : 08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTYX	Ventyx Biosciences Inc
2024/02/28	06 : 01	GlobeNewswire Inc.	Ventyx Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Corporate Progress	NASDAQ:VTYX	Ventyx Biosciences Inc